HCPLive Network

Hyponatremia Discussion and Explanation

 
Below you will find parts 1 and 2 of “Hyponatremia Explained Clearly,” which are part of Dr. Roger Seheult’s terrific MedCram video series (which offers “Medical Topics Explained Clearly by World-Class Instructors”).
 
Hyponatremia Explained Clearly – Part 1
 

 
Hyponatremia Explained Clearly – Part 2 of 4
 

 
 
Visit the MedCram YouTube page to access parts 3 and 4, as well as dozens of other high-quality informative videos on a wide range of medical topics.
 

Further Reading
Hyponatremia must be managed with care, especially in patients with chronic severe illness, due to the unpredictable nature of tolvaptan to raise serum sodium levels.
Sodium picosulfate, a commonly prescribed medication for bowel prep prior to colonoscopy, is associated with increased risk of hyponatremia in older adults compared to polyethylene glycol.
Patients with decompensated heart failure and hyponatremia treated with standard management experienced worse outcomes than non-hyponatremic patients. Treatment with tolvaptan was associated with more favorable outcomes.
Information on diagnostic and therapeutic approaches to hyponatremia, including tolvaptan and other VRAs, will be presented at this year's conference.
Acute ischemic stroke patients with hyponatremia have worse stroke scale scores on admission and discharge as well as worse mortality rates in the hospital and at 3-month and 12-month follow-ups.
Recently released guidelines seek to provide clarity to the management of hyponatremia by outlining an evidence-based, patient-centered approach to diagnosis and treatment.
Hyponatremia is associated with increased mortality and rehospitalization in patients hospitalized for heart failure.
More Reading